Authors: Walczynski, K Guryn, R Zuiderveld, OP Zhang, MQ Timmerman, H

Citation: K. Walczynski et al., Histamine H-1 receptor ligands Part II. Synthesis and in vitro pharmacology of 2-[2-(phenylamino)thiazol-4-yl]ethanamine and 2-(2-benzhydrylthiazol-4-yl)ethanamine derivatives, FARMACO, 55(9-10), 2000, pp. 569-574

Authors: Walczynski, K Guryn, R Zuiderveld, OP Timmerman, H

Citation: K. Walczynski et al., Non-imidazole histamine H-3 ligands, part 2: New 2-substituted benzothiazoles as histamine H-3 antagonists, ARCH PHARM, 332(11), 1999, pp. 389-398

Authors: De Esch, IJP Vollinga, RC Goubitz, K Schenk, H Appelberg, U Hacksell, U Lemstra, S Zuiderveld, OP Hoffmann, M Leurs, R Menge, WMPB Timmerman, H

Citation: Ijp. De Esch et al., Characterization of the binding site of the histamine H-3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)cyclopropylamine, J MED CHEM, 42(7), 1999, pp. 1115-1122

Authors: Walczynski, K Timmerman, H Zuiderveld, OP Zhang, MQ Glinka, R

Citation: K. Walczynski et al., Histamine H-1 receptor ligands Part I. Novel thiazol-4-ylethanamine derivatives: synthesis and in vitro pharmacology, FARMACO, 54(8), 1999, pp. 533-541